BC

Bool Chand Nagpal

Director Director DIN 01588618
DIN 01588618 First appointment Jul 2009 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2009
Shareholding value Locked Premium profile

About Bool Chand Nagpal

Bool Chand Nagpal has 17 years in corporate governance. Formerly with 1 company, such as Ipzah Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01588618
Primary Designation Director
First Appointment 10 Jul 2009
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Director 10 Jul 2009 1982 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ipzah Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bool Chand Nagpal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bool Chand Nagpal

Bool Chand Nagpal has 17 years in corporate governance. Formerly with 1 company, such as Ipzah Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Bool Chand Nagpal is associated with 0 companies as a director.

Bool Chand Nagpal has expertise in General Business.

Bool Chand Nagpal has 17 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available